PS1023 MUTANT IDH1 INHIBITOR IVOSIDENIB (AG-120) IN COMBINATION WITH AZACITIDINE FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Authors :: Hartmut Döhner
Andre C. Schuh
Prapti A. Patel
Giovanni Martinelli
Jing Gong
Stephanie M. Kapsalis
Amir T. Fathi
Courtney Dinardo
S. de Botton
Du Hung Lam
Vickie Zhang
Anthony S. Stein
Richard Stone
Olga Frankfurt
Xuemei Wang
Amer M. Zeidan
Eytan M. Stein
Hagop M. Kantarjian
Thomas Winkler
Peter Tan
Denice Hickman
Bin Wu
Emmanuel Raffoux
Paresh Vyas
Source :: HemaSphere. 3:460-461
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: IDH1
business.industry
Mutant
Azacitidine
Cancer research
Medicine
Myeloid leukemia
Hematology
Newly diagnosed
business
medicine.drug

Full Text Access

Tools